| scholarly article | Q13442814 |
| P50 | author | Carmine Vacca | Q77373464 |
| P2093 | author name string | Roberta Bianchi | |
| Andrew L Mellor | |||
| Brendan Marshall | |||
| Francesca Fallarino | |||
| Paolo Puccetti | |||
| Ursula Grohmann | |||
| Ciriana Orabona | |||
| Maria C Fioretti | |||
| Maria L Belladonna | |||
| Derin B Keskin | |||
| P2860 | cites work | Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 |
| P433 | issue | 1 | |
| P921 | main subject | dendritic cell | Q506253 |
| Indoleamine 2,3-dioxygenase 1 | Q14907419 | ||
| P304 | page(s) | 65-68 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | International Immunology | Q15710043 |
| P1476 | title | Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells | |
| P478 | volume | 14 |
| Q27863347 | 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity |
| Q34541409 | 1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis |
| Q39611354 | 3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival |
| Q36376640 | A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice |
| Q46557704 | A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation |
| Q34222660 | A role for calreticulin in the pathogenesis of rheumatoid arthritis |
| Q35848222 | A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation |
| Q38941777 | ANALYSIS OF DENDRITIC CELL STIMULATION UTILIZING A MULTI-FACETED NANOPOLYMER DELIVERY SYSTEM AND THE IMMUNE MODULATOR 1-METHYL TRYPTOPHAN. |
| Q37039994 | Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression |
| Q35952614 | Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases |
| Q44024646 | Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase |
| Q33952214 | An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function |
| Q36016868 | Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouse |
| Q38268639 | Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research |
| Q36810606 | Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses |
| Q42040648 | CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment |
| Q80473538 | CD8alpha dendritic cells and immune protection from experimental allergic encephalomyelitis |
| Q36399304 | CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice |
| Q44170968 | CTLA-4-Ig regulates tryptophan catabolism in vivo. |
| Q36775804 | CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk |
| Q34356219 | CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2,3-dioxygenase |
| Q35843507 | Challenges and future perspectives of T cell immunotherapy in cancer |
| Q48578310 | Characterization of the Kynurenine Pathway in CD8+ Human Primary Monocyte-Derived Dendritic Cells. |
| Q43857730 | Cigarette smoke exposure hinders long-term allograft survival by suppressing indoleamine 2, 3-dioxygenase expression |
| Q79248342 | Comparative evaluation of CC chemokine-induced migration of murine CD8α+ and CD8α− dendritic cells and their in vivo trafficking |
| Q37014666 | Controlling pathogenic inflammation to fungi |
| Q34004810 | Dendritic cell-regulatory T-cell interactions control self-directed immunity |
| Q38033163 | Dendritic cells a double-edge sword in autoimmune responses |
| Q51364475 | Dendritic cells and regulation of alloimmune responses: relevance to outcome and therapy of organ transplantation. |
| Q38908238 | Dendritic cells as gatekeepers of tolerance. |
| Q36425922 | Dendritic cells as promoters of transplant tolerance |
| Q35161161 | Dendritic cells, T cell tolerance and therapy of adverse immune reactions |
| Q37650028 | Depressive disorder and gastrointestinal dysfunction after myocardial infarct are associated with abnormal tryptophan-5-hydroxytryptamine metabolism in rats |
| Q38000471 | Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase |
| Q33786188 | Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat protein |
| Q46121081 | Disease Tolerance Mediated by Phosphorylated Indoleamine-2,3 Dioxygenase Confers Resistance to a Primary Fungal Pathogen |
| Q34066721 | Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection. |
| Q46737044 | Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. |
| Q46945116 | Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo |
| Q28204166 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase |
| Q35835489 | Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. |
| Q37672486 | Gatekeepers of intestinal inflammation |
| Q38682156 | Harnessing the properties of dendritic cells in the pursuit of immunological tolerance |
| Q82540613 | High Levels of IDO-Expressing CD16+ Peripheral Cells, and Tregs in Graft Biopsies From Kidney Transplant Recipients Under Belatacept Treatment |
| Q38047057 | Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance. |
| Q42985603 | Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS. |
| Q34674495 | IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation |
| Q46941757 | IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells |
| Q29614752 | IDO expression by dendritic cells: tolerance and tryptophan catabolism |
| Q36944802 | IDO-expressing regulatory dendritic cells in cancer and chronic infection |
| Q37159129 | IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo |
| Q35794680 | Identification and characterization of CD8+ suppressor T cells. |
| Q51722040 | Immune cells from patients with psoriasis are defective in inducing indoleamine 2,3-dioxygenase expression in response to inflammatory stimuli. |
| Q35037009 | Immune dysregulation by the rheumatoid arthritis shared epitope |
| Q37386324 | Immune regulation by non-lymphoid cells in transplantation. |
| Q46455029 | Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination |
| Q91816563 | Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells |
| Q43191462 | Immunomodulatory effects of vitamin D: implications for GVHD. |
| Q34609461 | Immunoregulatory effects of indoleamine 2, 3-dioxygenase in transplantation |
| Q37144901 | Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. |
| Q36610873 | Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells |
| Q36821053 | Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity |
| Q35048483 | Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis |
| Q34655953 | Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. |
| Q28591402 | Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation |
| Q34973801 | Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy |
| Q38274532 | Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model |
| Q51597260 | Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study. |
| Q37301247 | Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study. |
| Q36395748 | Indoleamine-2,3-dioxygenase modulation of allergic immune responses |
| Q34983446 | Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease |
| Q35865362 | Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection |
| Q35155944 | L-arginine metabolism in myeloid cells controls T-lymphocyte functions. |
| Q81462602 | Long-term effects of IFN-gamma, IL-10, and TGF-beta-modulated dendritic cells on immune response in Lewis rats |
| Q36490474 | Lung dendritic cells and the inflammatory response |
| Q37522460 | Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases |
| Q90248643 | Metabolic host response and therapeutic approaches to influenza infection |
| Q36075227 | Metabolic mechanisms of tumor resistance to T cell effector function |
| Q26864319 | Metabolic reprogramming and metabolic dependency in T cells |
| Q38097311 | Modulating T regulatory cells in cancer: how close are we? |
| Q44632333 | Modulation of tryptophan catabolism by regulatory T cells. |
| Q37982065 | Modulation of tumor tolerance in primary central nervous system malignancies |
| Q38216015 | Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis |
| Q36041377 | Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). |
| Q35156717 | New insights into the functional role of the rheumatoid arthritis shared epitope |
| Q43083243 | Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells |
| Q37809070 | Novel Findings in Drug-Induced Dendritic Cell Tolerogenicity |
| Q36425407 | Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study |
| Q33766714 | Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study. |
| Q47298005 | Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells |
| Q34353313 | Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2 |
| Q35647362 | Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder |
| Q28388235 | Regulatory dendritic cells: there is more than just immune activation |
| Q41857863 | Retroviral and lentiviral vectors for the induction of immunological tolerance |
| Q28742855 | SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanism |
| Q36481079 | STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance |
| Q50096775 | Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice |
| Q39301153 | Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model |
| Q35219290 | Some interfaces of dendritic cell biology |
| Q36627360 | Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO |
| Q80118079 | Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells |
| Q38831208 | Suppression of Th1 differentiation by tryptophan supplementation in vivo |
| Q44137068 | T cell apoptosis by tryptophan catabolism |
| Q37334065 | T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase |
| Q37352554 | Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy |
| Q37340475 | The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity |
| Q34657284 | The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation |
| Q34438046 | The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity |
| Q36117580 | The potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth |
| Q34422017 | The role of dendritic cells in tissue-specific autoimmunity. |
| Q37413688 | Thymic indoleamine 2,3-dioxygenase-positive eosinophils in young children: potential role in maturation of the naive immune system |
| Q35711560 | Tolerance mechanisms and recent progress |
| Q96767810 | Transcriptomic profiling of bovine blood dendritic cells and monocytes following toll-like receptor stimulation |
| Q40686234 | Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division |
Search more.